Search research articles
Contact Us
Filters
Showing results (241-250 of 254) with videos related to
Page
of 26
Sort By:
The Journal of Clinical Investigation
|
May 11, 2023
PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis
Kallesh D Jayappa, Brian Tran, Vicki L Gordon, et al.
Nature Medicine
|
September 18, 2012
Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma
Lawrence N Kwong, James C Costello, Huiyun Liu, et al.
Gynecologic Oncology
|
May 29, 2018
A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer
Carol Aghajanian, Virginia Filiaci, Don S Dizon, et al.
Circulation Research
|
October 29, 2011
B-cell aortic homing and atheroprotection depend on Id3
Amanda C Doran, Michael J Lipinski, Stephanie N Oldham, et al.
Cell
|
January 28, 2020
Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth
Maojin Yao, P Britten Ventura, Ying Jiang, et al.
Nature Immunology
|
February 20, 2019
The transcription factor c-Myb regulates CD8<sup>+</sup> T cell stemness and antitumor immunity
Sanjivan Gautam, Jessica Fioravanti, Wei Zhu, et al.
Journal of Palliative Medicine
|
April 13, 2021
A Pilot Study of a Collaborative Palliative and Oncology Care Intervention for Patients with Head and Neck Cancer
Jessica R Bauman, Jessie R Panick, Thomas J Galloway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2022
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial
Joyce F Liu, Mark F Brady, Ursula A Matulonis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 27, 2022
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study
Larry J Copeland, Mark F Brady, Robert A Burger, et al.
Obstetrics and Gynecology
|
January 12, 2019
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma
Peter G Rose, James J Java, Ritu Salani, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 254) with videos related to
Sort By:
Page
of 26
The Journal of Clinical Investigation
|
May 11, 2023
PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis
Kallesh D Jayappa, Brian Tran, Vicki L Gordon, et al.
Nature Medicine
|
September 18, 2012
Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma
Lawrence N Kwong, James C Costello, Huiyun Liu, et al.
Gynecologic Oncology
|
May 29, 2018
A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer
Carol Aghajanian, Virginia Filiaci, Don S Dizon, et al.
Circulation Research
|
October 29, 2011
B-cell aortic homing and atheroprotection depend on Id3
Amanda C Doran, Michael J Lipinski, Stephanie N Oldham, et al.
Cell
|
January 28, 2020
Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth
Maojin Yao, P Britten Ventura, Ying Jiang, et al.
Nature Immunology
|
February 20, 2019
The transcription factor c-Myb regulates CD8<sup>+</sup> T cell stemness and antitumor immunity
Sanjivan Gautam, Jessica Fioravanti, Wei Zhu, et al.
Journal of Palliative Medicine
|
April 13, 2021
A Pilot Study of a Collaborative Palliative and Oncology Care Intervention for Patients with Head and Neck Cancer
Jessica R Bauman, Jessie R Panick, Thomas J Galloway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2022
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial
Joyce F Liu, Mark F Brady, Ursula A Matulonis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 27, 2022
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study
Larry J Copeland, Mark F Brady, Robert A Burger, et al.
Obstetrics and Gynecology
|
January 12, 2019
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma
Peter G Rose, James J Java, Ritu Salani, et al.
Page
of 26